Unlock instant, AI-driven research and patent intelligence for your innovation.

Triazolopyridazine compound and application thereof

A compound and triazolo technology, applied in the field of triazolopyridazine compounds, can solve problems such as single structure

Active Publication Date: 2022-06-07
SHANGHAI SIMR BIOTECHNOLOGY CO LTD +1
View PDF16 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0007] The technical problem to be solved by the present invention is that the existing pair of α 5 -GABA A The structure of the compound with selective reverse regulation activity of the receptor is relatively simple, so the present invention provides a triazolopyridazine compound and its application

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Triazolopyridazine compound and application thereof
  • Triazolopyridazine compound and application thereof
  • Triazolopyridazine compound and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0130] Method A

[0131] 3-(7-(tert-butyl)-6-((6-methyl-6,7-dihydro-5H-pyrrolo[3,4-b]pyridin-2-yl)methoxy)- [1,2,4]Triazolo[4,3-b]pyridazin-3-yl)-5-methylisoxazole

[0132]

[0133] 3-(7-(tert-butyl)-6-(((6,7-dihydro-5H-pyrrolo[3,4-b]pyridin-2-yl)methoxy)-[1,2 ,4]Triazolo[4,3-b]pyridazin-3-yl)-5-methylisoxazole (100 mg, 0.25 mmol, intermediate 38) was dissolved in methanol (1.5 mL), cyano was added Sodium borohydride (46 mg, 0.75 mmol), the mixture was stirred at room temperature for 10 minutes, then 37% aqueous formaldehyde solution (1 mL) was added, and the reaction mixture was stirred at room temperature for 3 hours. An appropriate amount of 1 M aqueous sodium hydroxide solution was added to the reaction solution to quench the reaction, Dichloromethane (20 mL) was extracted three times, the organic phases were combined, washed three times with water (10 mL), dried over anhydrous sodium sulfate, filtered, and the filtrate was concentrated to obtain the title compound...

Embodiment 6

[0135] Method B

[0136] 3-(7-(tert-butyl)-6-((6-(1-ethylpyrrolidin-3-yl)pyridin-2-yl)methoxy)-[1,2,4]triazole [4,3-b]pyridazin-3-yl)-5-methylisoxazole

[0137]

[0138] 3-(7-(tert-butyl)-6-chloro-[1,2,4]triazolo[4,3-b]pyridazin-3-yl)-5-methylisoxazole (100 mg , 0.34 mmol), (6-(1-ethylpyrrolidin-3-yl)pyridin-2-yl)methanol (60 mg, 0.34 mmol) and cesium carbonate (225 mg, 0.7 mmol) were sequentially added to acetonitrile (5 mL) , the mixture was reacted at 50 °C overnight. The reaction solution was added to water (20 mL), extracted three times with dichloromethane (20 mL), dried and concentrated, and purified by preparative thin layer chromatography (dichloromethane / methanol=10 / 1) to obtain the title compound (5 mg, yield 4%) as a white solid ). 1 HNMR (400MHz, DMSO-d6) δ 8.15 (s, 1 H), 7.86 (t, J=7.58 Hz, 1 H), 7.55 (d, J=7.83 Hz, 1 H), 7.40 (d, J=7.34 Hz, 1 H), 6.97 (s, 1 H), 5.61 (s, 2 H), 3.68 - 3.78 (m, 1 H), 3.59 (br. s., 2 H), 3.15 - 3.24 (m, 2 H), 3.06 (d, J=...

Embodiment 23

[0140] Method E

[0141] 3-(7-(tert-butyl)-6-(((2-methyl-2,3-dihydro-1H-pyrrolo[3,4-c]pyridin-6-yl)methoxy)- [1,2,4]Triazolo[4,3-b]pyridazin-3-yl)-5-methylisoxazole hydrochloride

[0142]

[0143] 3-(7-(tert-butyl)-6-((2,3-dihydro-1H-pyrrolo[3,4-c]pyridin-6-yl)methoxy)-[1,2, 4] Triazolo[4,3-b]pyridazin-3-yl)-5-methylisoxazole (60 mg, 0.15 mmol) was dissolved in a mixed solvent of dichloromethane and methanol (1 mL / 1 mL), divided into Sodium cyanoborohydride (30 mg, 0.45 mmol) and 37% formaldehyde solution (40 mg, 0.45 mmol) were added in batches, and the mixture was stirred at room temperature for half an hour. The reaction solution was quenched by adding 1M aqueous sodium hydroxide solution, extracted three times with an appropriate amount of dichloromethane, the organic phases were combined, 4M hydrogen chloride ethyl acetate solution (0.2 mL) was added, the precipitated solid was collected by filtration, and dried to obtain the title compound (24 mg) , yield 32%). ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Resistanceaaaaaaaaaa
Login to View More

Abstract

The invention discloses a triazolopyridazine compound and application of the triazolopyridazine compound. The present invention provides a substance X or a pharmaceutically acceptable salt thereof; the substance X is a triazolopyridazine compound I or a stereoisomer thereof. The compound has the characteristics of good selective reverse regulation activity, bioavailability and the like on an alpha5-GABAA receptor.

Description

technical field [0001] The present invention relates to a triazolopyridazine compound and its application. Background technique [0002] Gamma-aminobutyric acid (GABA) is an important inhibitory neurotransmitter in the mammalian central nervous system. There are two types of GABA receptors in nature, one is GABA A Receptors, which are members of the ligand-gated ion channel superfamily, and GABA B receptors, which are members of the G protein-coupled receptor superfamily. GABA in mammals A Receptor subunits are found in α1-6, β1-4, γ1-3, δ, ε, θ and ρ1-3 subunits, among which α, β and γ subunits form a complete functional GABA A receptors are essential, and the alpha subunit benzodiazepines are associated with GABA A Receptor binding is critical. [0003] GABA with α5 A receptors (α5-GABA A receptor) GABA in the mammalian brain A The proportion of receptors is less than 5%, and the expression level is very low in the cerebral cortex, but GABA in the hippocampus of t...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07D519/00A61K31/5025A61P25/24A61P25/04A61P25/28A61P9/10A61P25/22A61P25/00A61P25/18A61P3/04A61P15/00A61P25/16A61P25/08A61P9/14
CPCC07D519/00A61P25/24A61P25/04A61P25/28A61P9/10A61P25/22A61P25/00A61P25/18A61P3/04A61P15/00A61P25/16A61P25/08A61P9/14
Inventor 王非孙勇吴金华陈南阳
Owner SHANGHAI SIMR BIOTECHNOLOGY CO LTD